In the Media
InMed Pharmaceuticals Inc. (IMLFF) Announces NSERC Grant to The University of British Columbia
InMed Pharmaceuticals Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF),...
Source: Marijuana Stocks
InMed Files Patent Application for its Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of...
Source: City Biz List